Impact of Time Intervals of Preparation on Quality and Tolerance of the Bowel Preparation
NCT ID: NCT02908919
Last Updated: 2016-11-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
480 participants
INTERVENTIONAL
2016-08-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fortrans pulv. sol
Polyethylene glycol solution. Used 4 l before colonoscopy. Bowel preparation interval: QD/BID or one day.
Colonoscopy
The quality of bowel preparation, which is checked during colonoscopy
Picoprep pulv. sol.
Natrium picosulfate/ magnesium citrate solution. Used 2 l before colonoscopy. bowel preparation interval: QD/BID or one day.
Colonoscopy
The quality of bowel preparation, which is checked during colonoscopy
Moviprep pulv. sol.
Polyethylene glycol + ascorbic acid solution. Used 2 l before colonoscopy. Bowel preparation interval: QD/BID or one day.
Colonoscopy
The quality of bowel preparation, which is checked during colonoscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colonoscopy
The quality of bowel preparation, which is checked during colonoscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* known or suspected bowel obstruction
* active bowel inflammation
* pregnancy
* any presence of serious medical conditions ( esp. cardiac, renal, liver diseases)
* history of prior colonic or rectal surgery
* inability to obtain valid data from
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nemocnice T.Bati, Zlin
UNKNOWN
Brno University Hospital
OTHER
University Hospital, Motol
OTHER
Faculty Hospital Kralovske Vinohrady
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MUDr. Jan Matous
Jan Matous, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jan Matous, MD
Role: PRINCIPAL_INVESTIGATOR
Faculty Hospital Kralovske Vinohrady, Prague
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty Hospital Kralovske Vinohrady
Prague, , Czechia
Nemocnice T.Bati
Zlín, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jan Matous, MD
Role: primary
Vladimir Kojecky, MD,PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CB1601
Identifier Type: -
Identifier Source: org_study_id